|
1.
|
Raizer JJ, Grimm S, Chamberlain MC, et al:
A phase 2 trial of single-agent bevacizumab given in an
every-3-week schedule for patients with recurrent high-grade
gliomas. Cancer. 116:5297–5305. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Gilbert CA and Ross AH: Cancer stem cells:
cell culture, markers, and targets for new therapies. J Cell
Biochem. 108:1031–1038. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Bonavia R, Inda MM, Cavenee WK and Furnari
FB: Heterogeneity maintenance in glioblastoma: a social network.
Cancer Res. 71:4055–4060. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Masica DL and Karchin R: Correlation of
somatic mutation and expression identifies genes important in human
glioblastoma progression and survival. Cancer Res. 71:4550–4061.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Huang PH, Cavenee WK, Furnari FB and White
FM: Uncovering therapeutic targets for glioblastoma: a systems
biology approach. Cell Cycle. 6:2750–2754. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Hide T, Takezaki T, Nakatani Y, et al:
Combination of a ptgs2 inhibitor and an epidermal growth factor
receptor-signaling inhibitor prevents tumorigenesis of
oligodendrocyte lineage-derived glioma-initiating cells. Stem
Cells. 29:590–599. 2011. View
Article : Google Scholar
|
|
7.
|
Murphy AM and Rabkin SD: Current status of
gene therapy for brain tumors. Transl Res. 161:339–354. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Gong A and Huang S: FoxM1 and
Wnt/β-catenin signaling in glioma stem cells. Cancer Res.
72:5658–5662. 2012.
|
|
9.
|
Filatova A, Acker T and Garvalov BK: The
cancer stem cell niche(s): the crosstalk between glioma stem cells
and their microenvironment. Biochim Biophys Acta. 1830:2496–2508.
2013. View Article : Google Scholar
|
|
10.
|
Altaner C and Altanerova V: Stem cell
based glioblastoma gene therapy. Neoplasma. 59:756–760. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Patel M, Vogelbaum MA, Barnett GH, Jalali
R and Ahluwalia MS: Molecular targeted therapy in recurrent
glioblastoma: current challenges and future directions. Expert Opin
Investig Drugs. 21:1247–1266. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Serakinci N, Christensen R, Fahrioglu U,
Sorensen FB, Dagnæs-Hansen F, Hajek M, Jensen TH, Kolvraa S and
Keith NW: Mesenchymal stem cells as therapeutic delivery vehicles
targeting tumor stroma. Cancer Biother Radiopharm. 26:767–773.
2011. View Article : Google Scholar
|
|
13.
|
Bak XY, Lam DH, Yang J, Ye K, Wei EL, Lim
SK and Wang S: Human embryonic stem cell-derived mesenchymal stem
cells as cellular delivery vehicles for prodrug gene therapy of
glioblastoma. Hum Gene Ther. 22:1365–1377. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Dai LJ, Moniri MR, Zeng ZR, Zhou JX, Rayat
J and Warnock GL: Potential implications of mesenchymal stem cells
in cancer therapy. Cancer Lett. 305:8–20. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Hata N, Shinojima N, Gumin J, Yong R,
Marini F, Andreeff M and Lang FF: Platelet-derived growth factor BB
mediates the tropism of human mesenchymal stem cells for malignant
gliomas. Neurosurgery. 66:144–157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Matuskova M, Baranovicova L, Kozovska Z,
Durinikova E, Pastorakova A, Hunakova L, Waczulikova I, Nencka R
and Kucerova L: Intrinsic properties of tumour cells have a key
impact on the bystander effect mediated by genetically engineered
mesenchymal stromal cells. J Gene Med. 14:776–787. 2012. View Article : Google Scholar
|
|
17.
|
Keung EZ, Nelson PJ and Conrad C: Concise
review: genetically engineered stem cell therapy targeting
angiogenesis and tumor stroma in gastrointestinal malignancy. Stem
Cells. 31:227–235. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Kosaka H, Ichikawa T, Kurozumi K, Kambara
H, Inoue S, Maruo T, Nakamura K, Hamada H and Date I: Therapeutic
effect of suicide gene-transferred mesenchymal stem cells in a rat
model of glioma. Cancer Gene Ther. 19:572–578. 2012. View Article : Google Scholar
|
|
19.
|
Doucette T, Rao G, Yang Y, Gumin J,
Shinojima N, Bekele BN, Qiao W, Zhang W and Lang FF: Mesenchymal
stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma
model. Neoplasia. 13:716–725. 2011.PubMed/NCBI
|
|
20.
|
Liu Y, Wang L, Fatahi R, Kronenberg M,
Kalajzic I, Rowe D, Li Y and Maye P: Isolation of murine bone
marrow derived mesenchymal stem cells using Twist2 Cre transgenic
mice. Bone. 47:916–925. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Kisiel AH, McDuffee LA, Masaoud E, Bailey
TR, Esparza Gonzalez BP and Nino-Fong R: Isolation,
characterization, and in vitro proliferation of canine mesenchymal
stem cells derived from bone marrow, adipose tissue, muscle, and
periosteum. Am J Vet Res. 73:1305–1317. 2012. View Article : Google Scholar
|
|
22.
|
Dembo M and Wang YL: Stresses at the
cell-to-substrate interface during locomotion of fibroblasts.
Biophys J. 76:2307–2316. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Qin L, Huang J, Xiong C, Zhang Y and Fang
J: Dynamical stress characterization and energy evaluation of
single cardiac myocyte actuating on flexible substrate. Biochem
Biophys Res Commun. 360:352–356. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Huang J, Peng X, Xiong C and Fang J:
Influence of substrate rigidity on primary nucleation of cell
adhesion: a thermal fluctuation model. J Colloid Interface Sci.
366:200–208. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Lee J, Elkahloun AG, Messina SA, Ferrari
N, Xi D, Smith CL, Cooper R Jr, Albert PS and Fine HA: Cellular and
genetic characterization of human adult bone marrow-derived neural
stem-like cells: a potential antiglioma cellular vector. Cancer
Res. 63:8877–8889. 2003.
|
|
26.
|
Paroo Z, Ye X, Chen S and Liu Q:
Phosphorylation of the human microRNA-generating complex mediates
MAPK/Erk signaling. Cell. 139:112–122. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Liu N, Landreh M, Cao K, et al: The
microRNA miR-34 modulates ageing and neurodegeneration in
Drosophila. Nature. 482:519–523. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Bischoff DS, Makhijani NS and Yamaguchi
DT: Constitutive expression of human telomerase enhances the
proliferation potential of human mesenchymal stem cells. Biores
Open Access. 1:273–279. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Sensebé L, Bourin P and Tarte K: Good
manufacturing practices production of mesenchymal stem/stromal
cells. Hum Gene Ther. 22:19–26. 2011.PubMed/NCBI
|
|
30.
|
Boeuf S and Richter W: Chondrogenesis of
mesenchymal stem cells: role of tissue source and inducing factors.
Stem Cell Res Ther. 1:312010.PubMed/NCBI
|
|
31.
|
Uccelli A, Morando S, Bonanno S, Bonanni
I, Leonardi A and Mancardi G: Mesenchymal stem cells for multiple
sclerosis: does neural differentiation really matter? Curr Stem
Cell Res Ther. 6:69–72. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Augello A and De Bari C: The regulation of
differentiation in mesenchymal stem cells. Hum Gene Ther.
21:1226–1238. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Park JS, Chu JS, Tsou AD, Diop R, Tang Z,
Wang A and Li S: The effect of matrix stiffness on the
differentiation of mesenchymal stem cells in response to TGF-β.
Biomaterials. 32:3921–3930. 2011.PubMed/NCBI
|
|
34.
|
Galli R, Binda E, Orfanelli U, Cipelletti
B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F and Vescovi
A: Isolation and characterization of tumorigenic, stem-like neural
precursors from human glioblastoma. Cancer Res. 64:7011–7021.
2004.PubMed/NCBI
|
